1-6 of 6
Ji-ichiro Sasaki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2962: Development of the LCMS bioanalysis for clinical pharmacokinetics of antibody drugs using Fab-selective limited proteolysis (nSMOL)

Takashi Shimada, Noriko Iwamoto, Sho Saeki, Ji-ichiro Sasaki, Taka-Aki Sato, Akinobu Hamada
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2962.
https://doi.org/10.1158/1538-7445.AM2016-2962
Published: 15 July 2016
View article titled, Abstract 2962: Development of the LCMS bioanalysis for clinical pharmacokinetics of antibody drugs using Fab-selective limited proteolysis (nSMOL)
Journal Articles

Abstract 5481: Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer

Chihiro Endo-Tsukude, Ji-ichiro Sasaki, Sho Saeki, Norihiro Iwamoto, Megumi Inaba, Sunao Ushijima, Hiroto Kishi, Shinji Fujii, Hiroshi Semba, Kosuke Kashiwabara, Yukari Tsubata, Yuki Kai, Hideyuki Saito, Takeshi Isobe, Hirotsugu Kohrogi, Akinobu Hamada
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5481.
https://doi.org/10.1158/1538-7445.AM2015-5481
Published: 01 August 2015
View article titled, Abstract 5481: Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer
Journal Articles

Abstract 5459: Association of CYP1A1 and CYP3A5 polymorphisms with pharmacokinetics of erlotinib in patients with non-small cell lung cancer

Yuki Kai, Akinobu Hamada, Ji-ichiro Sasaki, Sho Saeki, Norihiro Iwamoto, Megumi Inaba, Sunao Ushijima, Maki Urata, Hiroto Kishi, Shinji Fujii, Hiroshi Semba, Kosuke Kashiwabara, Isobe Takeshi, Hirotsugu Kourogi, Hideyuki Saito
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5459.
https://doi.org/10.1158/1538-7445.AM2011-5459
Published: 15 April 2011
View article titled, Abstract 5459: Association of CYP1A1 and CYP3A5 polymorphisms with pharmacokinetics of erlotinib in patients with non-small cell lung cancer
Journal Articles

Abstract 3588: Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Akinobu Hamada, Ji-ichiro Sasaki, Sho Saeki, Norihiro Iwamoto, Megumi Inaba, Sunao Ushijima, Maki Urata, Hiroto Kishi, Shinji Fujii, Hiroshi Semba, Yuki Kai, Hideyuki Saito
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3588.
https://doi.org/10.1158/1538-7445.AM10-3588
Published: 15 April 2010
View article titled, Abstract 3588: Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib
Journal Articles

Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells

Masahiko Nishizaki, Ji-ichiro Sasaki, Bingliang Fang, Edward. N. Atkinson, John D. Minna, Jack A. Roth, Lin Ji
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5745–5752.
https://doi.org/10.1158/0008-5472.CAN-04-0195
Published: 16 August 2004
View article titled, Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells
Open the PDF for Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells in another window
Journal Articles

Anti–mitotic function of a synthetic compound MMPT disrupting microtubule polymerization in human lung cancer cell lines

Fuminori Teraishi, Shuhong Wu, Ji-Ichiro Sasaki, Lidong Zhang, Hong-Bo Zhu, John J. Davis, Dietmar Jacob, Bingliang Fang
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1249.
Published: 01 April 2004
View article titled, Anti–mitotic function of a synthetic compound MMPT disrupting microtubule polymerization in human lung cancer cell lines